Text

Nutrigenomics: from Biofarma an innovative approach to cardiometabolic diseases

Biofarma Group has consolidated its expertise in the formulation of dietary supplements aimed at cardiometabolic well-being.

Leaky gut is linked to accelerated biological aging in people with HIV

The findings of a recent study suggest that specific microbial signatures are associated with accelerated biological aging.

A gut microbial metabolite may promote blood clot formation

The findings of a recent study suggest that 2MBC exacerbates the susceptibility to thrombosis and may explain why people with COVID-19 are at increased thrombotic risk.

Gut bacteria may contribute to devastating eye diseases

The findings of a recent study suggest that inherited eye diseases are caused in part by gut bacteria that travel to the retina.

The microbiotas of men who have sex with men resemble those of non-Westernized people

The findings of a recent study suggest that specific sexual activities are associated with gut microbiota alterations in men who have sex with men.

New era in infant nutrition: Lallemand Health Solutions and dsm-firmenich formulate synbiotic solutions

Isabelle Champié: “At Lallemand Health Solutions, we are committed to pushing the boundaries of probiotic research and development to create solutions that promote optimal health and well-being.

Flow cytometry: from Biofarma Group, a new approach for probiotic counting

A team of researchers have carried out a study on the search for bacterial probiotics, using a new method: flow cytometry

Advanced long-read sequencing services revolutionize microbiome analysis

Clinical Microbiomics sets a new standard in microbial research with unmatched data precision and resolution.

Mouth bacteria speed up pancreatic cancer growth in mice

Research done in mice shows that the mouth-dwelling bacterium Porphyromonas gingivalis can travel from the mouth to the pancreas, resulting in lesions that lead to cancer.

Sacco System unveils new biotech development site in Brisbane

Sacco System announces the grand opening of its development site in Australia.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top